Provision of ibritumomab for the treatment of lymphoma

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Provision of ibritumomab for the treatment of lymphoma
Principal Investigator
Professor Kwong, Yok Lam   (Principal Investigator (PI))
Co-Investigator(s)
Dr Liu King Yin   (Co-Investigator)
Duration
24
Start Date
2008-01-01
Amount
480000
Conference Title
Provision of ibritumomab for the treatment of lymphoma
Presentation Title
Keywords
ibritumomab, lymphoma
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
207212
Grant Type
S.K. Yee Medical Foundation - General Award
Funding Year
2007
Status
Completed
Objectives
Provide yttrium-90 ibritumomab tiuxetan (Zevalin) treatment to patients with relapsed or refractory follicular lymphoma that is resistant to rituximab.